Rockwell Research Development from 2010 to 2026

RMTI Stock  USD 1.00  0.03  2.91%   
Rockwell Medical's Research Development is decreasing with slightly volatile movements from year to year. Research Development is predicted to flatten to about 20.8 K. For the period between 2010 and 2026, Rockwell Medical, Research Development quarterly trend regression had mean deviation of  9,036,797 and range of 48.3 M. View All Fundamentals
 
Research Development  
First Reported
2000-03-31
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Rockwell Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rockwell Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 M, Interest Expense of 1.4 M or Total Revenue of 122.5 M, as well as many indicators such as Price To Sales Ratio of 0.68, Dividend Yield of 0.0 or PTB Ratio of 1.66. Rockwell financial statements analysis is a perfect complement when working with Rockwell Medical Valuation or Volatility modules.
  
Build AI portfolio with Rockwell Stock
Check out the analysis of Rockwell Medical Correlation against competitors.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.
The Research Development trend for Rockwell Medical offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Rockwell Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Rockwell Medical's Research Development Growth Pattern

Below is the plot of the Research Development of Rockwell Medical over the last few years. It is Rockwell Medical's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rockwell Medical's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Rockwell Research Development Regression Statistics

Arithmetic Mean9,548,757
Geometric Mean2,131,772
Coefficient Of Variation143.60
Mean Deviation9,036,797
Median6,321,400
Standard Deviation13,711,810
Sample Variance188T
Range48.3M
R-Value(0.56)
Mean Square Error138.5T
R-Squared0.31
Significance0.02
Slope(1,510,144)
Total Sum of Squares3008.2T

Rockwell Research Development History

202620.8 K
202521.9 K
202419 K
20231.1 M
20223.1 M
20216.8 M
20207.1 M

About Rockwell Medical Financial Statements

Investors use fundamental indicators, such as Rockwell Medical's Research Development, to determine how well the company is positioned to perform in the future. Although Rockwell Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Research Development21.9 K20.8 K

Currently Active Assets on Macroaxis

When determining whether Rockwell Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rockwell Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rockwell Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rockwell Medical Stock:
Check out the analysis of Rockwell Medical Correlation against competitors.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is there potential for Health Care Equipment & Supplies market expansion? Will Rockwell introduce new products? Factors like these will boost the valuation of Rockwell Medical. Anticipated expansion of Rockwell directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.17)
Revenue Per Share
2.201
Quarterly Revenue Growth
(0.44)
Return On Assets
(0.05)
Return On Equity
(0.17)
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Rockwell Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Rockwell Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Rockwell Medical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.